How Past Gene Therapy Approvals Are Shaping the Future with Dr. Peter Marks
ARM’s recent briefing at 2024 JPM, ARM’s CEO, Tim Hunt stated there are up to 17 possible U.S. and EU approvals this year. In this segment, Dr. Peter Marks shared what he and his team have learned from current gene therapy approvals to accelerate future approvals.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Thermo Fisher Scientific Bioproduction
This website uses cookies to ensure you get the best experience on our website. Learn more